Home » Artec to Test Tubercin in South Africa
Artec to Test Tubercin in South Africa
Artec has received the final plan to study Tubercin, a polysaccharide compound used as an immunostimulant, in HIV and tuberculosis patients in South Africa.
The company will reveal more details shortly and expects to begin treatment in early 2008.
Artec also is planning to use a product based on Tubercin in patients at wellness centers in the Bahamas in 2008, the company said.
Upcoming Events
-
21Mar
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr